In the midst of the largest measles outbreak in decades, experts say adults who have an elevated risk of encountering the disease should think about reupping their vaccinations. Meanwhile, officials say the U.S. is nearing the tipping point that measles would no longer be considered an "eliminated" disease.
from Kaiser Health News http://bit.ly/2Lilyc3
May 01, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
DNA Can Curl Up To Keep Vulnerable Bits Away From Predators, Making CRISPR Technology IneffectiveBut this problem is only the latest in an expanding list of challenges with the technology, including genomic havoc and concerns about cancer. Meanwhile, an appeals court has struck down a challenge to a CRISPR patent ruling.… Read More
After Unplanned Pregnancies, European Regulators Set To Release Study Of ‘Natural Cycles’ App Approved By FDAWhile touted by the FDA as a safe and effective form of contraception if used carefullly, Natural Cycles is raising eyebrows overseas, highlighting the difficulties regulators face in different countries with new technologies… Read More
State Highlights: North Carolina’s Senior Residents Brace For Oncoming Storm; Calif. Nurses Claim Restrictive Timekeeping Software Has Led To Unpaid OvertimeMedia outlets report on news from North Carolina, California, Maryland, Missouri, West Virginia, Georgia, Minnesota, Arizona, Texas, Colorado, Washington, Ohio and Wisconsin. from Kaiser Health News https://ift.tt/2CK6MXk … Read More
Parsing Policy: Health Law Protections Poised To Deliver Senate, House To Democrats. Even In Red States?Opinion writers weigh in on the country's growing concerns about losing health care protections under President Trump. from Kaiser Health News https://ift.tt/2CK768u … Read More
Perspectives: Kavanaugh, Conservative Supreme Court Would Put Women’s Reproductive Rights At Severe RiskOpinion writers express views on the impact Brett Kavanaugh could have on the future of abortion rights. from Kaiser Health News https://ift.tt/2NsxjwD … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment